Outcomes and assessments
SECONDARY
The primary and secondary outcomes of the present study included changes from baseline (day 1, prior to the study treatment) in T cells, cytokines, and SARS-CoV-2 RNA on day 8. The primary outcome was the change rate of peripheral CD8Clinical outcomes included the change in oxygen saturation measured by pulse oximetry (SpO